Valeo Financial Advisors, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$157,000
-50.6%
333,574
-38.8%
0.01%
-74.2%
Q4 2019$318,000
+148.4%
544,968
+65.1%
0.03%
+106.7%
Q2 2019$128,000
-30.8%
330,0000.0%0.02%
-31.8%
Q1 2019$185,000
+42.3%
330,0000.0%0.02%
+22.2%
Q4 2018$130,000
-14.5%
330,0000.0%0.02%
-14.3%
Q3 2018$152,000
-1.9%
330,0000.0%0.02%
-4.5%
Q2 2018$155,000330,0000.02%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Cypress Capital Management LLC (WY) 234,225$132,0000.18%
Noven Financial Group, Inc. 123,772$70,0000.04%
Harvest Investment Services, LLC 109,443$60,0000.04%
GSA CAPITAL PARTNERS LLP 559,489$314,0000.03%
COURIER CAPITAL LLC 354,973$199,0000.03%
Valeo Financial Advisors, LLC 330,000$185,0000.02%
Transform Wealth, LLC 205,481$115,0000.02%
WEDBUSH SECURITIES INC 326,793$184,0000.02%
STEEL GROVE CAPITAL ADVISORS, LLC 55,500$31,0000.02%
MONTAG A & ASSOCIATES INC 230,000$129,0000.01%
View complete list of AMPIO PHARMACEUTICALS INC shareholders